The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(tert-butylcarbamoyl)piperidin-4-yl)-N-(4-(4,5-dimethyl-6-oxo-1,6-dihydropyridazin-3-yl)-3-ethylphenyl)-1H-indazole-3-carboxamide ID: ALA4437906
PubChem CID: 155513050
Max Phase: Preclinical
Molecular Formula: C32H39N7O3
Molecular Weight: 569.71
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cc(NC(=O)c2nn(C3CCN(C(=O)NC(C)(C)C)CC3)c3ccccc23)ccc1-c1n[nH]c(=O)c(C)c1C
Standard InChI: InChI=1S/C32H39N7O3/c1-7-21-18-22(12-13-24(21)27-19(2)20(3)29(40)36-35-27)33-30(41)28-25-10-8-9-11-26(25)39(37-28)23-14-16-38(17-15-23)31(42)34-32(4,5)6/h8-13,18,23H,7,14-17H2,1-6H3,(H,33,41)(H,34,42)(H,36,40)
Standard InChI Key: GUCSYQHDCYSRTM-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 46 0 0 0 0 0 0 0 0999 V2000
16.4662 -15.8485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4651 -16.6681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1731 -17.0770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8828 -16.6676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8800 -15.8449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1713 -15.4397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1748 -17.8920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4654 -18.2999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4648 -19.1163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1730 -19.5259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8831 -19.1131 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8802 -18.2980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1689 -14.6225 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8754 -14.2118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8729 -13.3946 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5843 -14.6182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6713 -15.4268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4711 -15.5944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3290 -14.2798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8749 -14.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6720 -14.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9244 -13.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3734 -13.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5783 -13.5066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8726 -16.2984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1739 -20.3431 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4615 -16.9980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8595 -17.6999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6703 -17.7084 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.0814 -17.0089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6818 -16.3008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0724 -18.4199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6573 -19.1238 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.8895 -18.4273 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.2916 -19.1388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1088 -19.1462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8766 -19.8427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6956 -19.8437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7570 -17.0761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0497 -16.6669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7568 -19.5244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7582 -17.8904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 1 0
12 7 2 0
3 7 1 0
6 13 1 0
13 14 1 0
14 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 20 1 0
19 16 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
18 25 1 0
10 26 2 0
25 27 1 0
25 31 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
29 32 1 0
32 33 2 0
32 34 1 0
34 35 1 0
35 36 1 0
35 37 1 0
35 38 1 0
2 39 1 0
39 40 1 0
9 41 1 0
8 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 569.71Molecular Weight (Monoisotopic): 569.3114AlogP: 5.36#Rotatable Bonds: 5Polar Surface Area: 125.01Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.88CX Basic pKa: ┄CX LogP: 4.23CX LogD: 4.23Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.30Np Likeness Score: -1.41
References 1. O'Malley DP, Ahuja V, Fink B, Cao C, Wang C, Swanson J, Wee S, Gavai AV, Tokarski J, Critton D, Paiva AA, Johnson BM, Szapiel N, Xie D.. (2019) Discovery of Pyridazinone and Pyrazolo[1,5-a]pyridine Inhibitors of C-Terminal Src Kinase., 10 (10): [PMID:31620238 ] [10.1021/acsmedchemlett.9b00354 ]